Previous work clearly demonstrated that IL-6 could promote intestinal inflammation and cancer development (14), whereas interleukin-10 (IL-10) coordinated regulatory T cells to suppress inflammation and carcinogenesis (15). This evidence concerns the gene IL10 and cancer.